Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
investing succesffuly to reach your goals investing succesffuly to reach your goals
X

Smruthi Organics Ltd Stock Analysis

Small Cap
Evaluated by 223 users | BSE: 540686 | NSE: |
Pharmaceuticals & Drugs

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
Return on Capital Employed 22.87%11.55%-3.33%0.16%6.08%7.07%-0.58%15.14%13.51%27.74%-
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 20618193.776.673.879.497.3137131127128
Y-o-Y Gr. Rt.--12.1%-48.3%-18.3%-3.6%7.6%22.7%41.2%-4.6%-3.5%-
Adjusted EPS (Rs.) 9.235.4-5.63-3.350.611.38-2.8165.2614.9114.55
Y-o-Y Gr. Rt.--41.5%-204.3%NANA126.2%-303.6%NA-12.3%183.5%-
Book Value per Share (Rs.) 31.2535.9630.5925.7426.8128.225.3931.7837.152.8555.06
Adjusted Net Profit 10.66.2-6.4-3.80.71.6-3.26.9617.117
Net Op. Cash Flow (Rs. Cr.) 12.65.49.28.5149.25.112.121.422.8-
Debt to Cash Flow from Ops 2.578.645.035.192.623.485.982.290.730.43-
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Smruthi Organics Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  10 yrs 5 yrs 3 yrs 1 yr
Net Sales -5.3%11.4%9.1%-3.5%
Adjusted EPS 5.5%89.5%NA183.5%
Book Value per Share 614.527.742.5
Share Price - - 85% 264.6%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
Return on Equity (%) 33.9716.07-16.91-11.892.325.03-10.520.9915.2933.1426.97
Operating Profit Margin (%) 12.4910.481.716.0514.3612.553.3512.4712.1222.5621.33
Net Profit Margin (%) 5.123.41-6.87-5.010.952-3.3154.613.4913.01
Debt to Equity 0.91.131.311.51.190.991.060.760.370.16-
Working Capital Days 123158293334317258194155163139-
Cash Conversion Cycle 416910393999080665849-
Loading price chart...
Entity Percentage Holding
Promoters 63.39%
Non-Institutions 36.61%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

Data is not available for this company.

Data is not available for this company

Data is not available for this company.

Smruthi Organics Ltd is a mid-size, public limited, API manufacturing company from Solapur, India. Smruthi Organics Ltd was established in1989 by qualified technocrats and has very good experience and reputation in the pharmaceutical industry for the supply of quality products. 

Their core competency is multi-step organic synthesis and large scale manufacturing of organic molecules. Their focus has always been API for the regulated markets. They have been part
Smruthi Organics Ltd is a mid-size, public limited, API manufacturing company from Solapur, India. Smruthi Organics Ltd was established in1989 by qualified technocrats and has very good experience and reputation in the pharmaceutical industry for the supply of quality products. 

Their core competency is multi-step organic synthesis and large scale manufacturing of organic molecules. Their focus has always been API for the regulated markets. They have been part of successful contract manufacturing and custom synthesis agreements with leading European, American and Japanese customers. They are currently expanding our R&D to become a one-stop solution provider from concept to execution for all API including, but not restricted to, the following: 
  • Process Development
  • Process Optimization
  • Process Validation
  • Analytical Methods Validation
  • Regulatory Support and DMF Registrations
  • Commercial Manufacturing

Their constant endeavor to improve operations and systems has contributed to our growth. they encourage operational transparency with customers, which complements to confidence building for stronger relationships. Customer satisfaction is their highest priority and they constantly strive on optimizing delivery times of all their services.

Smruthi Organics Ltd facility is USFDA approved and European GMP certified for Carbidopa, Metformin HCL and Norfloxacin. It has successfully filed 4 European and US drug master files for different products.

Smruthi can manage a potential molecule's entire development life cycle up to commercialization through rigorous planning and proper execution. Smruthi can independently or in conjunction with the customer develop optimized synthesis process, perform scale-up and process validations, compile DMF and provide the customer with regulatory support for finished formulation dossier registration. The engagement can be either on an FTE or deliverables basis. We respect absolute confidentiality in such sensitive relationships enhancing smooth exchange of information.

Product range of the company includes:

API   
  • Amlodipine Base
  • Amlodipine Besilate
  • Carbidopa
  • Carvedilol
  • Chlorhexidine Base
  • Chlorhexidine Salts
  • Ciprofloxacin HCI
  • Clofibrate
  • Diloxanide Furoate
  • Enrofloxacin
  • Fenofibrate
  • Fluconazole
  • Iopomidol
  • Metformin HCI
  • Norfloxacin
  • Pefloxacin
  • S-Amlodipine
  • Nabumetone
Drug Intermediate
  • Nabumetone
  • Iopamidol / Iohexol
  • Montelukast
  • Iopamidol
  • Co-enzyme Q10
  • Atorvastatin
  • Carvedilol
  • Ciprofloxacin/Enrofloxacin
  • Perindopril
Achievements/ recognition:
  • The company’s quality systems and facilities are approved by USFDA, EU – GMP and ISO 9001:2000. 

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback